Business
SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization
TAMPA, FL, March 25, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to announce Michele Rath as Senior Vice President and Chief Commercial Officer (CCO) of Scienture, LLC, a wholly owned s
About this update from Scienture Holdings, Inc.
[{"type":"image","alt":"Scienture Holdings, Inc.","displaySize":"","headline":null,"caption":"Scienture Holdings, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":51,"url":"https://media.zenfs.com/en/globenewswire.com/28b8170836e8ea967b4f044154f8d636"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/13RYlt0th1D5Rsmp1JUGQA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTcxO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/28b8170836e8ea967b4f044154f8d636","width":300,"height":51}},"lazy":false},{"type":"text","content":"TAMPA, FL, March 25, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to announce Michele Rath as Senior Vice President and Chief Commercial Officer (CCO) of Scienture, LLC, a wholly owned subsidiary of the Company, leading and managing Scienture, LLC’s commercial operations. Under Ms. Rath’s leadership, Scienture, LLC has formalized a strategic relationship with Syneos Health Commercial Services, LLC (“Syneos Health”), a premier biopharmaceutical solutions organization, by executing a Master Commercial Services Agreement with Syneos Health (the “MCSA”). Pursuant to the MCSA, Syneos Health will serve as Scienture, LLC’s Contract Sales Organization (CSO). This collaboration is set to enhance Scienture, LLC’s commercial capabilities and expand its market reach through Syneos Health’s proven expertise in outsourced sales solutions.","length":1150,"tagName":"p"},{"type":"text","content":"Ms. Rath, who joined Scienture in a full time capacity on November 1, 2024, brings over 20 years of industry experience, having previously served in key leadership roles at Pfizer, CVS Caremark and Aurobindo Pharma. With a proven track record in driving sales strategy, strategic marketing, sales operations and market access, she will spearhead Scienture, LLC’s commercial initiatives, focusing on revenue growth, strategic partnerships, and customer engagement.","length":463,"tagName":"p"},{"type":"text","content":"Additionally, Scienture, LLC will leverage Syneos Health’s comprehensive suite of commercial services to d...